A novel laser-cut fully covered metal stent with anti-reflux valve in patients with malignant distal biliary obstruction refractory to conventional covered metal stent.
anti-reflux metal stent
distal biliary obstruction
malignant
recurrent biliary obstruction
refractory
Journal
Journal of hepato-biliary-pancreatic sciences
ISSN: 1868-6982
Titre abrégé: J Hepatobiliary Pancreat Sci
Pays: Japan
ID NLM: 101528587
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
revised:
08
03
2021
received:
31
01
2021
accepted:
04
04
2021
pubmed:
10
4
2021
medline:
16
10
2021
entrez:
9
4
2021
Statut:
ppublish
Résumé
Stenting against recurrent biliary obstruction (RBO) after placement of covered metal stent (CMS) for distal malignant biliary obstruction (MBO) is still challenging. This study investigated the feasibility of a novel laser-cut fully CMS with anti-reflux valve in patients with distal MBO refractory to conventional CMS. Patients who underwent Duckbill-type metal stent (DMS) placement between June 2019 and May 2020 were included. Early complications, causes of RBO including non-occlusion cholangitis, and time to RBO (TRBO) were evaluated. TRBO of DMS was also compared with that of previous CMS. Thirty patients were included: pancreatic cancer/metastatic lymph nodes in 29 patients/one patient; duodenal stenosis in 13 patients. Technical and functional success were achieved in all patients. Mild cholangitis and mild pancreatitis developed in each one. Median follow-up period was 167 days (range, 23-527 days). RBO occurred in nine patients (30%): sludge formation in four patients, hemobilia in one patient, symptomatic distal stent migration in three patients, and non-occlusion cholangitis in one patient. TRBO of DMS was significantly longer than that of previous CMS (median 224 days vs median 120 days, P = .0025). DMS was successfully removed in all of six patients when re-intervention was needed. Duckbill-type metal stent might be safe and effective in patients with distal MBO refractory to conventional CMS.
Sections du résumé
BACKGROUND
BACKGROUND
Stenting against recurrent biliary obstruction (RBO) after placement of covered metal stent (CMS) for distal malignant biliary obstruction (MBO) is still challenging. This study investigated the feasibility of a novel laser-cut fully CMS with anti-reflux valve in patients with distal MBO refractory to conventional CMS.
METHODS
METHODS
Patients who underwent Duckbill-type metal stent (DMS) placement between June 2019 and May 2020 were included. Early complications, causes of RBO including non-occlusion cholangitis, and time to RBO (TRBO) were evaluated. TRBO of DMS was also compared with that of previous CMS.
RESULTS
RESULTS
Thirty patients were included: pancreatic cancer/metastatic lymph nodes in 29 patients/one patient; duodenal stenosis in 13 patients. Technical and functional success were achieved in all patients. Mild cholangitis and mild pancreatitis developed in each one. Median follow-up period was 167 days (range, 23-527 days). RBO occurred in nine patients (30%): sludge formation in four patients, hemobilia in one patient, symptomatic distal stent migration in three patients, and non-occlusion cholangitis in one patient. TRBO of DMS was significantly longer than that of previous CMS (median 224 days vs median 120 days, P = .0025). DMS was successfully removed in all of six patients when re-intervention was needed.
CONCLUSIONS
CONCLUSIONS
Duckbill-type metal stent might be safe and effective in patients with distal MBO refractory to conventional CMS.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
563-571Informations de copyright
© 2021 Japanese Society of Hepato-Biliary-Pancreatic Surgery.
Références
Nakai Y, Isayama H, Wang HP, Rerknimitr R, Khor C, Yasuda I, et al. International consensus statements for endoscopic management of distal biliary stricture. J Gastroenterol Hepatol. 2020;35:967-79.
Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488-92.
Al ST, Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc. 2015;82:256-267.e7.
Tringali A, Hassan C, Rota M, Rossi M, Mutignani M, Aabakken L. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy. 2018;50:631-41.
Misra SP, Dwivedi M. Reflux of duodenal contents and cholangitis in patients undergoing self-expandable metal stent placement. Gastrointest Endosc. 2009;70:317-21.
Zhang R, Luo H, Pan Y, Zhao L, Dong J, Liu Z, et al. Rate of duodenal-biliary reflux increases in patients with recurrent common bile duct stones: evidence from barium meal examination. Gastrointest Endosc. 2015;82:660-5.
Hamada T, Isayama H, Nakai Y, Togawa O, Kogure H, Kawakubo K, et al. Duodenal invasion is a risk factor for the early dysfunction of biliary metal stents in unresectable pancreatic cancer. Gastrointest Endosc. 2011;74:548-55.
Hu B, Wang TT, Shi ZM, Wang SZ, Lu R, Pan YM, et al. A novel antireflux metal stent for the palliation of biliary malignancies: a pilot feasibility study (with video). Gastrointest Endosc. 2011;73:143-8.
Lee KJ, Chung MJ, Park JY, Lee DH, Jung S, Bang BW, et al. Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction. Dig Endosc. 2013;25:308-12.
Kim DU, Kwon CI, Kang DH, Ko KH, Hong SP. New antireflux self-expandable metal stent for malignant lower biliary obstruction: in vitro and in vivo preliminary study. Dig Endosc. 2013;25:60-6.
Hu B, Wang TT, Wu J, Shi ZM, Gao DJ, Pan YM. Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial. Endoscopy. 2014;46:120-6.
Hamada T, Isayama H, Nakai Y, Kogure H, Togawa O, Kawakubo K, et al. Novel antireflux covered metal stent for recurrent occlusion of biliary metal stents: a pilot study. Dig Endosc. 2014;26:264-9.
Hamada T, Isayama H, Nakai Y, Togawa O, Kogure H, Takahara N, et al. Antireflux metal stent with an antimigration system for distal malignant biliary obstruction: a feasibility pilot study. Surg Laparosc Endosc Percutan Tech. 2015;25:212-7.
Lee YN, Moon JH, Choi HJ, Choi MH, Lee TH, Cha SW, et al. Effectiveness of a newly designed antireflux valve metal stent to reduce duodenobiliary reflux in patients with unresectable distal malignant biliary obstruction: a randomized, controlled pilot study (with videos). Gastrointest Endosc. 2016;83:404-12.
Hamada T, Isayama H, Nakai Y, Togawa O, Takahara N, Uchino R, et al. Antireflux metal stent as a first-line metal stent for distal malignant biliary obstruction: a pilot study. Gut Liv. 2017;11:142-8.
Morita S, Arai Y, Sugawara S, Sone M, Sakamoto Y, Okusaka T, et al. Antireflux metal stent for initial treatment of malignant distal biliary obstruction. Gastroenterol Res Pract. 2018;2018:3805173.
Hamada T, Isayama H, Nakai Y, Iwashita T, Ito Y, Mukai T, et al. Antireflux covered metal stent for nonresectable distal malignant biliary obstruction: multicenter randomized controlled trial. Dig Endosc. 2019;31:566-74.
Kin T, Ishii K, Okabe Y, Itoi T, Katanuma A. Feasibility of biliary stenting to distal malignant biliary obstruction using a novel designed metal stent with duckbill-shaped anti-reflux valve. Dig Endosc 2020 Sep 2. https://doi.org/10.1111/den.13827. Online ahead of print.
Togawa O, Isayama H, Tsujino T, Nakai Y, Kogure H, Hamada T, et al. Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstruction. J Gastroenterol. 2013;48:1300-7.
Mutignani M, Tringali A, Shah G, Perri V, Familiari P, Iacopini F, et al. Combined endoscopic stent insertion in malignant biliary and duodenal obstruction. Endoscopy. 2007;39:440-7.
Isayama H, Hamada T, Yasuda I, Itoi T, Ryozawa S, Nakai Y, et al. Tokyo criteria 2014 for transpapillary biliary stenting. Dig Endosc. 2015;27:259-64.
Hamada T, Nakai Y, Isayama H. TOKYO criteria: standardized reporting system for endoscopic biliary stent placement. Gastrointest Interv. 2018;7:46-51.
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446-54.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452-8.
Renno A, Abdel-Aziz Y, Ahmed T, Alastal Y, Toseef J, Al-Abboodi Y, et al. Antireflux valve metal stent versus conventional self-expandable metal stent in distal malignant biliary obstruction: a systematic review and meta-analysis. Ann Gastroenterol. 2019;32:605-13.
Mandai K, Nakamura S, Uno K, Yasuda K. Successful re-intervention through stent mesh after novel antireflux covered metal biliary stent placement. Endoscopy. 2021;53(03):E94-E95. https://doi.org/10.1055/a-1201-3045
Kwon CI, Moon JP, Yun H, Jeong S, Koh DH, Lee WJ, et al. Evaluation of valve function in antireflux biliary metal stents. BMC Gastroenterol. 2018;18:150.
Nakai Y, Isayama H, Kogure H, Hamada T, Togawa O, Ito Y, et al. Risk factors for covered metallic stent migration in patients with distal malignant biliary obstruction due to pancreatic cancer. J Gastroenterol Hepatol. 2014;29:1744-9.
Sohal DPS, Kennedy EB, Cinar P, Conroy T, Copur MS, Crane CH, et al. Mestatatic pancreatic cancer: ASCO guideline update. J Clin Oncol. 2020 Aug 5:JCO2001364. https://doi.org/10.1200/JCO.20.01364. Online ahead of print.
Sasaki T, Takeda T, Sasahira N. Double stenting with EUS-CDS using a new anti-reflux metal stent for combined malignant biliary and duodenal obstruction. J Hepatobiliary Pancreat Sci. 2020;27:e15-e16.